328 related articles for article (PubMed ID: 35327549)
1. Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models.
Morale MG; Tamura RE; Rubio IGS
Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327549
[TBL] [Abstract][Full Text] [Related]
2. A review for clinicians: Prostate cancer and the antineoplastic properties of metformin.
Hankinson SJ; Fam M; Patel NN
Urol Oncol; 2017 Jan; 35(1):21-29. PubMed ID: 27836248
[TBL] [Abstract][Full Text] [Related]
3. Research Progress on the Use of Metformin in Leukemia Treatment.
Wang Q; Wei X
Curr Treat Options Oncol; 2024 Feb; 25(2):220-236. PubMed ID: 38286894
[TBL] [Abstract][Full Text] [Related]
4. Impact of Metformin and compound C on NIS expression and iodine uptake in vitro and in vivo: a role for CRE in AMPK modulation of thyroid function.
Abdulrahman RM; Boon MR; Sips HC; Guigas B; Rensen PC; Smit JW; Hovens GC
Thyroid; 2014 Jan; 24(1):78-87. PubMed ID: 23819433
[TBL] [Abstract][Full Text] [Related]
5. Metformin as an Anticancer Agent.
Vancura A; Bu P; Bhagwat M; Zeng J; Vancurova I
Trends Pharmacol Sci; 2018 Oct; 39(10):867-878. PubMed ID: 30150001
[TBL] [Abstract][Full Text] [Related]
6. What every dentist should know about metformin, diabetes, and cancer.
Frykenberg MR; Schneider A; Bashirelahi N
Gen Dent; 2015; 63(5):70-2. PubMed ID: 26325646
[TBL] [Abstract][Full Text] [Related]
7. Metformin Inhibits Progression of Head and Neck Squamous Cell Carcinoma by Acting Directly on Carcinoma-Initiating Cells.
Wu X; Yeerna H; Goto Y; Ando T; Wu VH; Zhang X; Wang Z; Amornphimoltham P; Murphy AN; Tamayo P; Chen Q; Lippman SM; Gutkind JS
Cancer Res; 2019 Sep; 79(17):4360-4370. PubMed ID: 31292160
[TBL] [Abstract][Full Text] [Related]
8. Metformin and cancer immunity.
Ma R; Yi B; Riker AI; Xi Y
Acta Pharmacol Sin; 2020 Nov; 41(11):1403-1409. PubMed ID: 32868904
[TBL] [Abstract][Full Text] [Related]
9. Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-β and p38/ERK MAPK signalling.
Ruiz-Mitjana A; Vidal-Sabanés M; Navaridas R; Perramon-Güell A; Yeramian A; Nicholson-Sabaté N; Egea J; Encinas M; Matias-Guiu X; Dolcet X
Biomed Pharmacother; 2023 Dec; 168():115817. PubMed ID: 37925934
[TBL] [Abstract][Full Text] [Related]
10. Metformin in Oncology - How Far Is Its Repurposing as an Anticancer Drug?
Pácal L; Kaňková K
Klin Onkol; 2020; 33(2):107-113. PubMed ID: 32303131
[TBL] [Abstract][Full Text] [Related]
11. Metformin: Insights into its anticancer potential with special reference to AMPK dependent and independent pathways.
Ikhlas S; Ahmad M
Life Sci; 2017 Sep; 185():53-62. PubMed ID: 28755883
[TBL] [Abstract][Full Text] [Related]
12. Metformin: from mechanisms of action to therapies.
Foretz M; Guigas B; Bertrand L; Pollak M; Viollet B
Cell Metab; 2014 Dec; 20(6):953-66. PubMed ID: 25456737
[TBL] [Abstract][Full Text] [Related]
13. Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress.
Lin YC; Wu MH; Wei TT; Lin YC; Huang WC; Huang LY; Lin YT; Chen CC
Oncotarget; 2014 Jan; 5(1):298-308. PubMed ID: 24457597
[TBL] [Abstract][Full Text] [Related]
14. Anti-diabetic drug metformin: challenges and perspectives for cancer therapy.
Snima KS; Pillai P; Cherian AM; Nair SV; Lakshmanan VK
Curr Cancer Drug Targets; 2014; 14(8):727-36. PubMed ID: 25329671
[TBL] [Abstract][Full Text] [Related]
15. Metformin and Breast Cancer: Molecular Targets.
Faria J; Negalha G; Azevedo A; Martel F
J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):111-123. PubMed ID: 30903363
[TBL] [Abstract][Full Text] [Related]
16. Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.
Guppy A; Jamal-Hanjani M; Pickering L
Future Oncol; 2011 Jun; 7(6):727-36. PubMed ID: 21675836
[TBL] [Abstract][Full Text] [Related]
17. Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells.
Cai H; Zhang Y; Han TK; Everett RS; Thakker DR
Int J Cancer; 2016 May; 138(9):2281-92. PubMed ID: 26669511
[TBL] [Abstract][Full Text] [Related]
18. An update on mode of action of metformin in modulation of meta-inflammation and inflammaging.
Khodadadi M; Jafari-Gharabaghlou D; Zarghami N
Pharmacol Rep; 2022 Apr; 74(2):310-322. PubMed ID: 35067907
[TBL] [Abstract][Full Text] [Related]
19. Impact of metformin on disease control and survival in patients with head and neck cancer: a retrospective cohort study.
Lee DJ; McMullen CP; Foreman A; Huang SH; Lu L; Xu W; de Almeida JR; Liu G; Bratman SV; Goldstein DP
J Otolaryngol Head Neck Surg; 2019 Jul; 48(1):34. PubMed ID: 31345259
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
